NCT03794466 is a clinical trial in Pelvic Congestive Syndrome, sponsored by University of Kansas Medical Center.

Who is sponsoring NCT03794466?

NCT03794466 is sponsored by University of Kansas Medical Center.

What condition does NCT03794466 study?

NCT03794466 studies Pelvic Congestive Syndrome, Pelvic Pain.

Is NCT03794466 still recruiting?

NCT03794466 is currently recruiting now. Last updated 23 March 2026.

Last reviewed 2026-03-23 · How we verify

NCT03794466

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Quantify the Degree of Pain Relief of Pelvic Congestion Syndrome Following Gonadal Vein Embolization

Recruiting now Last updated 23 March 2026

What this trial tests

trial in Pelvic Congestive Syndrome in 30 participants. Currently enrolling.

Timeline

10 May 2019

Primary endpoint
31 December 2026

31 December 2027

Quick facts

Lead sponsor	University of Kansas Medical Center
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	30
Start date	10 May 2019
Primary completion	31 December 2026
Estimated completion	31 December 2027
Sites	1 location across United States

Conditions studied

Pelvic Congestive Syndrome — all drugs for Pelvic Congestive Syndrome →
Pelvic Pain — all drugs for Pelvic Pain →

Sponsor

University of Kansas Medical Center

Who can join

18 and older, female only, with Pelvic Congestive Syndrome or Pelvic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective is to quantify the degree of pain relief in patients undergoing gonadal vein embolization with coils as well as identify clinical or imaging factors that are predictive of a positive response to treatment, or poor response to treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pelvic Congestive Syndrome

Currently open trials in the same condition.

NCT06124664 — Study of Venous Outflow From the Lower Limbs in Patients With Pelvic Varicosities · recruiting

Other University of Kansas Medical Center trials

Trials by the same sponsor.

NCT06636214 — Adapting Changing Talk: Online (CHATO) to CHATO-Inclusive · NA · not yet recruiting
NCT07528963 — KanSurvive 2.0: Testing Enhanced Models of Cancer Survivorship Care for Rural Cancer Survivors in Primary Care Practice · NA · enrolling by invitation
NCT07463755 — Low-Fidelity Driving Simulator Training in Parkinson's Disease. · NA · not yet recruiting
NCT07420621 — Preliminary Effectiveness of Enhanced Text Message + Incentives · NA · recruiting
NCT07491510 — Improving Prenatal Care to Reduce Early Onset Preeclampsia in Low-Income · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03794466 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Kansas Medical Center
Last refreshed: 23 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03794466.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing